Farnesoid X receptor: a new player in glucose metabolism?
Cariou
Bertrand
B
Unité de Recherche 545, Institut National de la Santé et de la Recherche Médicale, Départment d'Athérosclérose, Institut Pasteur de Lille & Faculté de Pharmacie, Université de Lille 2, BP245-59019 Lille, France.
Duran-Sandoval
Daniel
D
Kuipers
Folkert
F
Staels
Bart
B
D000818:Animals; D001647:Bile Acids and Salts / Q000378:metabolism*; D002986:Clinical Trials as Topic; D004268:DNA-Binding Proteins / Q000502:physiology*; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D051379:Mice; D008954:Models, Biological; D010729:Phosphoenolpyruvate Carboxykinase (GTP) / Q000502:physiology*; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors / Q000502:physiology*; D000099150:Receptor, Farnesoid X-Activated
D001647:Bile Acids and Salts; D004268:DNA-Binding Proteins; D005947:Glucose; D010729:Phosphoenolpyruvate Carboxykinase (GTP); D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D000099150:Receptor, Farnesoid X-Activated